RecruitingNCT07250347

AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT

Langue and Imaging-integrated Foundation Model for Gastric Cancer Detection and Staging Via Contrast-Enhanced CT: a Multicenter Study


Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment

8,000 participants

Start Date

Aug 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Accurate preoperative assessment of gastric cancer stage guides eligibility for endoscopic resection, extent of gastrectomy and lymphadenectomy, selection for neoadjuvant therapy, and use of staging laparoscopy. Contrast-enhanced CT (CECT) is guideline-endorsed for initial staging, yet performance varies across institutions and readers. This study will evaluate an artificial-intelligence (AI) system that analyzes routine CECT to detect gastric cancer and assign four-class T stage (T1-T4) and N stage (N0-N3) .


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study uses artificial intelligence (AI) to analyze CT scan images of stomach cancer patients to improve how accurately the cancer is detected and staged (how far it has spread) before surgery. It compares the AI findings to the actual surgical pathology results. No experimental treatment is involved. **You may be eligible if...** - You have a confirmed diagnosis of stomach (gastric) cancer - You had a contrast-enhanced CT scan before surgery - There was no sign of distant spread of cancer at the time of diagnosis - You received surgery with intent to cure and complete tissue analysis was done afterward **You may NOT be eligible if...** - You received any treatment (chemotherapy, radiation, etc.) before surgery - Your CT scan was of poor quality or could not be evaluated Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCT scan

preoperative contrast-enhanced CT


Locations(1)

The First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07250347


Related Trials